Fast and Secure Delivery Worldwide Express & Expedited Shipping Service
USD $540.00
Sprycel is a prescription medication that contains Dasatinib, a potent tyrosine kinase inhibitor. It is primarily used in the treatment of certain types of leukemia, including Philadelphia chromosome-positive chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Dasatinib works by blocking the action of a specific protein that promotes the growth of cancer cells, thereby helping to control the disease and improve patient outcomes.
IndiaSprycel (Dasatinib) is a medication used to treat certain types of cancer, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It works by inhibiting specific proteins that promote cancer cell growth.
Sprycel is indicated for the treatment of adults and children with:
The recommended dosage of Sprycel varies based on the condition being treated. It is typically taken once daily, with or without food. Always follow your healthcare provider's instructions regarding dosage.
Common side effects of Sprycel may include:
If you experience severe side effects or signs of an allergic reaction, seek medical attention immediately.
Before taking Sprycel, inform your doctor of any medical history, especially:
Regular monitoring may be necessary to ensure the medication is working effectively and to minimize risks.
Sprycel may interact with other medications, which can affect how it works or increase the risk of serious side effects. Provide your healthcare provider with a complete list of all medications you are currently taking.
Store Sprycel at room temperature, away from moisture and heat. Keep out of reach of children and pets.
Sprycel is a vital treatment option for patients with specific types of leukemia. Consult with your healthcare provider to determine if this medication is appropriate for you and to discuss any potential risks and benefits.
